InvestorsHub Logo
Followers 1
Posts 140
Boards Moderated 0
Alias Born 01/26/2017

Re: Doctor Detroit post# 12013

Thursday, 06/29/2017 2:53:04 PM

Thursday, June 29, 2017 2:53:04 PM

Post# of 16911
Canada is amazing in its response to health & welfare of its citizens... US, not so much.. apropos a buyout... needs to happen sooner than later ..no need to rehash reasons here.. I mentioned possible candidates in the past as ALKS & INVVY but will + a 3rd candidate TEVA.. ttnp sources the bup from TEVA & buys EVA from another supplier... TEVA has the resources to manufacture both & price probuphine competitively for volume profit world wide ... Apple Tree has been throwing millions at various ventures in hope of a hit; Braeburn will struggle to generate cash soon.. probuphine will continue to be a challenge short term & Braeburn's reliance on injectables & implants face resistance from patients & providers due to their invasive nature (as opposed to taking a pill) .. point being TEVA can probably buy the rights to US & Canada probuphine from Apple Tree for what it's currently worth.. not all that much.. & given their manufacturing & distribution infrastructure they can profit substantially by marketing the product world wide.. + because of the complicated process of manufacture for proneura, there will be a barrier to entry for other manufacturers, even after the patent expires .. win win for TEVA
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News